88 related articles for article (PubMed ID: 22681384)
41. Detection of trisomy 21 by quantitative fluorescent-polymerase chain reaction in uncultured amniocytes.
Solassol J; Rahil H; Sapin V; Lemery D; Dastugue B; Boespflug-Tanguy O; Creveaux I
Prenat Diagn; 2003 Apr; 23(4):287-91. PubMed ID: 12673631
[TBL] [Abstract][Full Text] [Related]
42. Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes.
D'Anna R; Baviera G; Cannata ML; De Vivo A; Di Benedetto A; Corrado F
Gynecol Obstet Invest; 2007; 64(2):65-8. PubMed ID: 17264515
[TBL] [Abstract][Full Text] [Related]
43. Down syndrome screening: imagining the screening test of the future.
Koster MP; Heetkamp KM; Pennings JL; de Vries A; Visser GH; Schielen PC
Expert Rev Mol Diagn; 2010 May; 10(4):445-57. PubMed ID: 20465499
[TBL] [Abstract][Full Text] [Related]
44. Gene expression analysis of cultured amniotic fluid cell with Down syndrome by DNA microarray.
Chung IH; Lee SH; Lee KW; Park SH; Cha KY; Kim NS; Yoo HS; Kim YS; Lee S
J Korean Med Sci; 2005 Feb; 20(1):82-7. PubMed ID: 15716609
[TBL] [Abstract][Full Text] [Related]
45. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
46. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
Ashwood ER; Cheng E; Luthy DA
Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
[TBL] [Abstract][Full Text] [Related]
47. Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection.
Maymon E; Romero R; Pacora P; Gervasi MT; Edwin SS; Gomez R; Seubert DE
Am J Obstet Gynecol; 2000 Jun; 182(6):1545-53. PubMed ID: 10871477
[TBL] [Abstract][Full Text] [Related]
48. [Prenatal diagnosis of common chromosomal aneuploidies on uncultured amniotic fluid cells by fluorescence in situ hybridization].
Xiao HM; Tan YQ; Li LY; Lu GX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):608-10. PubMed ID: 15583993
[TBL] [Abstract][Full Text] [Related]
49. Amniotic fluid lipopolysaccharide-binding protein and soluble CD14 as mediators of the inflammatory response in preterm labor.
Gardella C; Hitti J; Martin TR; Ruzinski JT; Eschenbach D
Am J Obstet Gynecol; 2001 May; 184(6):1241-8. PubMed ID: 11349195
[TBL] [Abstract][Full Text] [Related]
50. Amniotic fluid concentrations of collagenase-1 and collagenase-3 are increased in polyhydramnios.
Fortunato SJ; Menon R; Ahmed NU; Bourgeois M; Dildy GA
J Perinat Med; 2004; 32(2):122-5. PubMed ID: 15085886
[TBL] [Abstract][Full Text] [Related]
51. Combining beta-core fragment and total oestriol measurements to test for Down syndrome pregnancies.
Cole LA; Acuna E; Isozaki T; Palomaki GE; Bahado-Singh RO; Mahoney MO
Prenat Diagn; 1997 Dec; 17(12):1125-33. PubMed ID: 9467809
[TBL] [Abstract][Full Text] [Related]
52. The association between congenital heart disease and Down syndrome in prenatal life.
Paladini D; Tartaglione A; Agangi A; Teodoro A; Forleo F; Borghese A; Martinelli P
Ultrasound Obstet Gynecol; 2000 Feb; 15(2):104-8. PubMed ID: 10775990
[TBL] [Abstract][Full Text] [Related]
53. [Diagnosis of Down's syndrome using short tandem repeat loci D21S11, D21S1440 and Penta D].
Shi YF; Li XZ; Li Y; Zhang XL; Zhang Y; Yue TF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Aug; 29(4):443-6. PubMed ID: 22875503
[TBL] [Abstract][Full Text] [Related]
54. Pyridoxine-related metabolite concentrations in normal and Down syndrome amniotic fluid.
Baggot PJ; Eliseo AJ; DeNicola NG; Kalamarides JA; Shoemaker JD
Fetal Diagn Ther; 2008; 23(4):254-7. PubMed ID: 18417989
[TBL] [Abstract][Full Text] [Related]
55. Myo-inositol in Down syndrome amniotic fluid. A case-control study.
Santamaria A; Corrado F; Interdonato ML; Baviera G; Carlomagno G; Cavalli P; Unfer V; D'Anna R
Prenat Diagn; 2014 Sep; 34(9):917-8. PubMed ID: 24933110
[No Abstract] [Full Text] [Related]
56. Amniotic fluid metabolic fingerprinting indicated metabolites which may play a role in the pathogenesis of foetal Down syndrome - a preliminary report.
Parfieniuk E; Pietrowska K; Samczuk P; Kretowski A; Ciborowski M; Zbucka-Kretowska M
Ginekol Pol; 2021; 92(3):188-194. PubMed ID: 33576476
[TBL] [Abstract][Full Text] [Related]
57. Amniotic Fluid Angiogenic and Inflammatory Factor Profiling in Foetal Down Syndrome.
Zbucka-Kretowska M; Charkiewicz K; Czerniecki J; Goscik J; Wolczynski S; Laudanski P
Fetal Diagn Ther; 2018; 44(1):44-50. PubMed ID: 28715807
[TBL] [Abstract][Full Text] [Related]
58. Quantitative proteomic analysis of Down syndrome in the umbilical cord blood using iTRAQ.
Sui W; Zhang R; Chen J; He H; Cui Z; Ou M; Li W; Qi S; Wen J; Lin X; Dai Y
Mol Med Rep; 2015 Feb; 11(2):1391-9. PubMed ID: 25369867
[TBL] [Abstract][Full Text] [Related]
59. Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses.
Slonim DK; Koide K; Johnson KL; Tantravahi U; Cowan JM; Jarrah Z; Bianchi DW
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9425-9. PubMed ID: 19474297
[TBL] [Abstract][Full Text] [Related]
60. Amniotic fluid and urine metabolomic alterations associated with pregnant women with Down syndrome fetuses.
Chen X; Hu L; Su J; Liu X; Luo X; Pei Y; Gao Y; Wei F
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7882-7889. PubMed ID: 34130603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
